TargetMol Chemicals Inc.

TargetMol Chemicals Inc.

Current Location: HOME >> Product
Product Categories
Country: China
Tel:
Mobile: 15002134094
E-mail:
QQ:
Skype: Chat Now!
Product Name MF CAS Details
MS934 C52H69F3IN7O6S 2756323-15-4 Details
αvβ6 integrin inhibitor 2 C21H30N4O3 313709-47-6 Details
FEN1-IN-7 C16H14N2O6S 824983-90-6 Details
Du011 C20H15F2NO4S 890818-51-6 Details
JGK-068S C22H23BrFN5O2 2490431-16-6 Details
URAT1 inhibitor 5 C18H14BrN3O2S 2102670-94-8 Details
WRN inhibitor 1 2923008-44-8 Details
BVFP C13H8BrF3N2O 357158-20-4 Details
β-Catenin modulator-1 C21H28N2O4S 1053086-89-7 Details
TH-Z827 C30H38N6O 2847881-81-4 Details
KRAS G12C inhibitor 58 2915599-52-7 Details
JBI-589 C29H28FN5O 2308504-22-3 Details
GSK3839919A C36H46ClN3O3 2081127-77-5 Details
CARM1-IN-3 C24H32N4O2 912970-67-3 Details
Pim-1 kinase inhibitor 5 2928606-67-9 Details
Antibacterial agent 157 2573134-85-5 Details
cGAS-IN-1 C18H19NO8 858770-07-7 Details
Topoisomerase inhibitor 2 C23H23N5O4 2713986-17-3 Details
Antibacterial agent 135 C11H15N5O6S 2233569-54-3 Details
Firazorexton hydrate 2861934-86-1 Details
Amoxicillin-clavulanate potassium C24H29KN4O10S 74469-00-4 Details
Pentabromopseudilin C10H4Br5NO 10245-81-5 Details
GlcNAcstatin C20H27N3O4 922163-64-2 Details
FX-06 C133H216N44O38 88650-17-3 Details
HDAC-IN-55 C17H17N3O3 1268674-16-3 Details
Canlitinib C33H31F2N3O7 2222730-78-9 Details
NSC194598 C20H19N3O 5358-76-9 Details
BDM91270 2892824-11-0 Details
5-Fluoromethylornithine dihydrochloride C6H14ClFN2O2 124796-41-4 Details
URAT1 inhibitor 8 C19H13ClFN3O4S 1632005-33-4 Details
Skp2 inhibitor 2 C27H32N4O 2760612-77-7 Details
FEN1-IN-5 C21H17N3O4S 824983-93-9 Details
ERK1/2 inhibitor 9 C31H32ClN7O3 2169302-75-2 Details
MMV009085 C22H22N2O6 298217-59-1 Details
NLRP3-IN-18 C19H18ClN3O 2769040-06-2 Details
JAK-IN-25 C19H17N5O4 2127110-22-7 Details
Bleximenib oxalate C32H50FN7O3.C2H2O4 2866179-95-3 Details
ELOVL6-IN-3 C27H24F3N3O3 712346-06-0 Details
AA74-1 C16H28N4O2 1361532-00-4 Details
Bio-AMS C20H29N9O7S2 1393881-52-1 Details
Cisd2 agonist 1 C14H13FN2O3S 2916371-54-3 Details
CVN636 C19H20FNO4S 2226732-62-1 Details
Verazine C27H43NO 14320-81-1 Details
SJ995973 C37H40ClN7O5S 2882065-25-8 Details
Patritumab deruxtecan 2227102-46-5 Details
EGGGG-PEG8-amide-bis(deoxyglucitol) C49H91N9O28 2842855-38-1 Details
PB038 C98H149FN12O36 2851058-71-2 Details
MC-Gly-Gly-Phe-Gly-Cyclobutanecarboxylic-Exatecan C55H60FN9O13 2414393-22-7 Details
Ac-Lys-Val-Cit-PABC-MMAE C66H108N12O14 1650569-89-3 Details
INX-SM-56 C32H36N2O6S 2734878-18-1 Details
MC-Val-Cit-PAB-Exatecan C53H60FN9O12 2504068-28-2 Details
Mal-PEG2-Val-Cit-PABA C27H38N6O9 1662687-83-3 Details
Bi-Mc-VC-PAB-MMAE C71H104N12O18 1620837-70-8 Details
MC-Val-Cit-PAB-NH-C2-NH-Boc C36H54N8O10 1616727-22-0 Details
7-Aminomethyl-10-methyl-11-fluoro camptothecin C22H20FN3O4 2378616-23-8 Details
KRAS inhibitor FB9 C23H21ClF4N2O5 2042365-57-9 Details
KRAS G12C inhibitor 1R C31H36ClFN6O2 2927439-07-2 Details
Ras inhibitor 134 C23H21ClFN5O3 2648552-54-7 Details
CeMMEC1 HCl C19H17ClN2O4 2095432-53-2 Details
KT-531 C17H14F4N2O4S 2490284-18-7 Details
HFY-4A C20H19N3O2 2094810-82-7 Details
(3aR,9aR)-Fluparoxan C10H10FNO2 105182-47-6 Details
Fluparoxan hydrochloride C10H11ClFNO2 105227-44-9 Details
(6Z)-7-Phenyl-7-(3-Pyridinyl)-6-Heptenoic Acid C18H19NO2 89667-39-0 Details
Compound STL565749 C19H17N3O 879771-67-2 Details
Inbakicept 2135939-52-3 Details
Budipine Hydrochloride C21H28ClN 63661-61-0 Details
VKGILS-NH2 TFA C30H55F3N8O9 2828432-41-1 Details
Metronidazole hydrochloride C6H9N3O3.ClH 69198-10-3 Details
3,7-dimethylocta-2,6-dienyl 5,9,13-trimethyltetradeca-4,8,12-enoate C27H44O2 16898-88-7 Details
TMV-IN-3 C28H26O4 2883408-35-1 Details
TMV-IN-2 C27H23FO4 2883408-32-8 Details
PROTAC EZH2 Degrader-1 C54H67N7O8 2641601-67-2 Details
SNIPER(TACC3)-11 C51H66N10O7S2 2906151-68-4 Details
YM281 C56H71N7O9S 2230914-84-6 Details
PCSK9-IN-3 C81H105FN15O15S2.C2HF3O2 2867496-34-0 Details
Tirilazad C38H52N6O2 110101-66-1 Details
Glycolithocholic acid 3-sulfate C26H43NO7S 15324-64-8 Details
N′-(2-Chloroethyl)-N-(4-methylcyclohexyl)-N-nitrosourea C10H18ClN3O2 75219-93-1 Details
Anticonvulsant agent 2 C21H17ClN2 75220-84-7 Details
UniPR505 C39H57N3O5 2938227-14-4 Details
LEM-14-1189 C35H34N6O5S2 2987501-17-5 Details
VEGFR-3-IN-1 C29H29ClF3N7OS 2756668-73-0 Details
SMS2-IN-2 C19H13ClFN3O2 2241838-28-6 Details
KRAS G12C inhibitor 56 C32H39N7O4S 2749963-77-5 Details
Type II TRK?inhibitor 1 C35H33F3N8O3 2937543-72-9 Details
SLC26A3-IN-1 C23H18O4 307552-53-0 Details
PERK-IN-6 C23H22N6O 1337532-14-5 Details
YM-58790 C27H31N3O2 168830-70-4 Details
PI5P4Ks-IN-2 C22H23N5 2766854-03-7 Details
Lanopepden mesylate C23H38FN7O7S 1441390-17-5 Details
Ainsliadimer A C30H34O7 1039431-94-1 Details
Naltrindole C26H26N2O3 111555-53-4 Details
Niravoline C22H25N3O3 130610-93-4 Details
Pateamine A C31H45N3O4S 139220-18-1 Details
Enerisant HCl C22H30N4O3.ClH 1152749-07-9 Details
CM-352 1542205-83-3 Details
ER-34122 C27H26ClN3O5 179325-62-3 Details
EPZ032597 C20H23N7O 1887193-58-9 Details
EPZ033294 C20H22ClN7O 1887195-17-6 Details
Product Total: Product Page:
94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214